Novartis AG - Depositary Receipt (Common Stock)
US ˙ NYSE ˙ US66987V1098

SecurityNVS / Novartis AG - Depositary Receipt (Common Stock)
InstitutionBoston Trust Walden Corp
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Boston Trust Walden Corp closes position in NVS / Novartis AG - Depositary Receipt (Common Stock)

On April 24, 2026 - Boston Trust Walden Corp filed a 13F-HR form disclosing ownership of 0 shares of Novartis AG - Depositary Receipt (Common Stock) (US:NVS) valued at $0 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 28, 2026 disclosing 2,096 shares of Novartis AG - Depositary Receipt (Common Stock). The current value of the position is $0 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-24 2026-03-31 13F NOVARTIS COMMON STOCK 66987V109 0 -100.00 0
2026-01-28 2025-12-31 13F NOVARTIS COMMON STOCK 66987V109 2,096 -44 -2.06 289 5.11 0.0013
2025-10-17 2025-09-30 13F NOVARTIS COMMON STOCK 66987V109 2,140 0 0.00 274 6.20 0.0020
2025-07-28 2025-06-30 13F NOVARTIS COMMON STOCK 66987V109 2,140 0 0.00 259 8.40 0.0018
2025-04-21 2025-03-31 13F NOVARTIS COMMON STOCK 66987V109 2,140 -65 -2.95 239 11.21 0.0017
2025-01-24 2024-12-31 13F NOVARTIS COMMON STOCK 66987V109 2,205 42 1.94 215 -13.71 0.0015
2024-10-24 2024-09-30 13F NOVARTIS COMMON STOCK 66987V109 2,163 20 0.93 249 8.77 0.0017
2024-07-19 2024-06-30 13F NOVARTIS COMMON STOCK 66987V109 2,143 44 2.10 228 12.32 0.0017
2024-04-22 2024-03-31 13F NOVARTIS COMMON STOCK 66987V109 2,099 0 0.00 203 -3.79 0.0014
2024-01-24 2023-12-31 13F NOVARTIS COMMON STOCK 66987V109 2,099 84 4.17 212 2.93 0.0016
2023-10-18 2023-09-30 13F NOVARTIS COMMON STOCK 66987V109 2,015 0 0.00 205 0.99 0.0017
2023-07-24 2023-06-30 13F NOVARTIS COMMON STOCK 66987V109 2,015 2,015 203 0.0017
2018-07-25 2018-06-30 13F NOVARTIS COMMON STOCK 66987V109 0 -47,560 -100.00 0 -100.00
2018-04-13 2018-03-31 13F NOVARTIS COMMON STOCK 66987V109 47,560 -1,400 -2.86 3,846 -6.45 0.0584
2018-01-29 2017-12-31 13F NOVARTIS COMMON STOCK 66987V109 48,960 3,800 8.41 4,111 6.04 0.0603
2017-10-13 2017-09-30 13F NOVARTIS COMMON STOCK 66987V109 45,160 0 0.00 3,877 2.87 0.0604
2017-07-19 2017-06-30 13F NOVARTIS COMMON STOCK 66987V109 45,160 1,200 2.73 3,769 15.44 0.0606
2017-04-24 2017-03-31 13F NOVARTIS COMMON STOCK 66987V109 43,960 1,625 3.84 3,265 5.90 0.0509
2017-02-07 2016-12-31 13F/A-1 NOVARTIS COMMON STOCK 66987V109 42,335 25 0.06 3,083 -7.72 0.0486
2017-02-01 2016-12-31 13F NOVARTIS COMMON STOCK 66987V109 42,335 3,083
2016-10-17 2016-09-30 13F NOVARTIS COMMON STOCK 66987V109 42,310 2,450 6.15 3,341 1.58 0.0551
2016-08-09 2016-06-30 13F NOVARTIS COMMON STOCK 66987V109 39,860 -525 -1.30 3,289 12.41 0.0562
2016-04-19 2016-03-31 13F NOVARTIS COMMON STOCK 66987V109 40,385 50 0.12 2,926 -15.68 0.0509
2016-01-21 2015-12-31 13F NOVARTIS COMMON STOCK 66987V109 40,335 -1,425 -3.41 3,470 -9.59 0.0644
2015-10-29 2015-09-30 13F NOVARTIS COMMON STOCK 66987V109 41,760 -2,600 -5.86 3,838 -12.03 0.0641
2015-07-17 2015-06-30 13F NOVARTIS COMMON STOCK 66987V109 44,360 -4,650 -9.49 4,363 -9.71 0.0665
2015-04-15 2015-03-31 13F NOVARTIS COMMON STOCK 66987V109 49,010 49,010 0.00 4,832 0.0717
2015-01-28 2014-12-31 13F NOVARTIS COMMON STOCK 66987V109 0 -48,110 -100.00 0 -100.00
2014-10-23 2014-09-30 13F NOVARTIS COMMON STOCK 66987V109 48,110 50 0.10 4,529 4.11 0.0699
2014-08-01 2014-06-30 13F NOVARTIS COMMON STOCK 66987V109 48,060 16,425 51.92 4,350 61.71 0.0632
2014-04-11 2014-03-31 13F NOVARTIS COMMON STOCK 66987V109 31,635 -446 -1.39 2,690 4.30 0.0400
2014-02-11 2013-12-31 13F NOVARTIS COMMON STOCK 66987V109 32,081 1,996 6.63 2,579 11.74 0.0376
2013-11-15 2013-09-30 13F NOVARTIS SPONSORED ADR 66987V109 30,085 25,643 577.29 2,308 635.03 0.0353
2013-08-08 2013-06-30 13F NOVARTIS COMMON STOCK 66987V109 4,442 4,442 314 0.0051
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.